After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Adverum Biotechnologies Inc is $69.56M. A total of 0.56 million shares were traded on the day, compared to an average of 247.41K shares.
In the most recent transaction, Leonard Braden Michael bought 20,407 shares of ADVM for 5.04 per share on Mar 26 ’25. After the transaction, the 10% Owner now owns 125,207 company shares. In a previous transaction on Mar 27 ’25, Leonard Braden Michael bought 16,593 shares at 5.19 per share. ADVM shares that 10% Owner owns now total 141,800.
Among the insiders who bought shares, Leonard Braden Michael acquired of 300,000 shares on Apr 22 ’25 at a per-share price of $3.00. This resulted in the 10% Owner holding 3,057,526 shares of ADVM after the transaction. In another insider transaction, Leonard Braden Michael bought 50,000 shares at $2.98 per share on Apr 23 ’25. Company shares held by the 10% Owner now total 191,800.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ADVM has a high of $10.84 and a low of $2.64.
As of this writing, ADVM has an earnings estimate of -$1.97 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$1.82 per share and a lower estimate of -$2.03.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ADVM’s latest balance sheet shows that the firm has $305.19M in Cash & Short Term Investments as of fiscal 2021. There were $102.99M in debt and $21.32M in liabilities at the time. Its Book Value Per Share was $3.39, while its Total Shareholder’s Equity was $316.19M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADVM is Buy with a score of 4.75.
